Portal de Periódicos da CAPES

Effects of medications on the periodontal tissues in health and disease

2006; Wiley; Volume: 40; Issue: 1 Linguagem: Inglês

10.1111/j.1600-0757.2005.00137.x

1600-0757

Robin A Seymour,

Peptidase Inhibition and Analysis

Periodontology 2000Volume 40, Issue 1 p. 120-129 Effects of medications on the periodontal tissues in health and disease Robin A. Seymour, Robin A. SeymourSearch for more papers by this author Robin A. Seymour, Robin A. SeymourSearch for more papers by this author First published: 04 January 2006 https://doi.org/10.1111/j.1600-0757.2005.00137.xCitations: 52Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Angelopoulos AP, Goaz PW. Incidence of diphenylhydantoin gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1972: 34: 898–906. 2 Barclay S, Thomason JM, Idle JR, Seymour RA. The incidence and severity of nifedipine-induced gingival overgrowth. J Clin Periodontol 1992: 19: 311–314. 3 Been V, Engel D. The effects of immunosuppressive drugs on periodontal inflammation in human renal allograft patients. J Periodontol 1982: 53: 245–258. 4 Bèokenkamp A, Bohnhorst B, Beier C, Albert N, Offner G, Brodehl J. Nifedipine aggravates cyclosporine A-induced gingival hyperplasia. Pediatr Nephrol 1994: 8: 181–185. 5 Birkeland SA. Uremia as a state of immune deficiency. Scand J Immunol 1976: 5: 107–115. 6 Bullon P, Machuca G, Martinez Sahuquillo A, Rojas J, Lacalle JR, Rios JV, Velasco E. Clinical assessment of gingival size among patients treated with diltiazem. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995: 79: 300–304. 7 Cebeci I, Kantarci A, Firatli E, Aygun S, Tanyeri H, Aydin AE, Carin M, Guc U, Tuncer O. Evaluation of the frequency of HLA determinants in patients with gingival overgrowth induced by cyclosporine-A. J Clin Periodontol 1996: 23: 737–742. 8 Chand DH, Quattrocchi J, Poe SA, Terezhalmy GT, Strife CF, Cunningham RJ. Trial of metronidazole vs. azithromycin for treatment of cyclosporine-induced gingival overgrowth. Pediatr Transplant 2004: 8: 60–64. 9 Cohen DW, Friedman L, Shapiro J, Kyle GC. A longitudinal investigation of the periodontal changes during pregnancy. J Periodontol 1969: 40: 563–570. 10 Daley TD, Wysocki GP, Day C. Clinical and pharmacologic correlations in cyclosporine-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1986: 62: 417–421. 11 Daley TD, Wysocki GP, Mamandras AH. Orthodontic therapy in the patient treated with cyclosporine. Am J Orthod Dentofacial Orthop 1991: 100: 537–541. 12 Davies DM, Ferner RE. Davies's Textbook of Adverse Drug Reactions, 5th edn. London: Chapman & Hall Medical, 1998. 13 Drew HJ, Vogel RI, Molofsky W, Baker H, Frank O. Effect of folate on phenytoin hyperplasia. J Clin Periodontol 1987: 14: 350–356. 14 Drozdzik M, Mysliwiec K, Lewinska-Chelstowska M, Banach J, Drozdzik A, Grabarek J. P-glycoprotein drug transporter MDR1 gene polymorphism in renal transplant patients with and without gingival overgrowth. J Clin Periodontol 2004: 31: 758–763. 15 Ellis JS, Seymour RA, Steele JG, Robertson P, Butler TJ, Thomason JM. Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study. J Periodontol 1999: 70: 63–67. 16 Ellis JS, Seymour RA, Taylor JJ, Thomason JM. Prevalence of gingival overgrowth in transplant patients immunosuppressed with tacrolimus. J Clin Periodontol 2004: 31: 126–131. 17 Esterberg HLW, PH. Sodium dilantin gingival hyperplasia. J Am Dent Assoc 1945: 32: 16–24. 18 Feldman RS, Szeto B, Chauncey HH, Goldhaber P. Non-steroidal anti-inflammatory drugs in the reduction of human alveolar bone loss. J Clin Periodontol 1983: 10: 131–136. 19 Goodson JM. A Potential Role of Prostaglandins in the Aetiology of Periodontal Disease. New York: Academic Press, 1973. 20 Haim G. Therapeutic effect of hydrocortisone on diseases affecting oral mucosa. Dent Abstr 1962: 7: 112. 21 Hassell TM, Hefti AF. Drug-induced gingival overgrowth: old problem, new problem. Crit Rev Oral Biol Med 1991: 2: 103–137. 22 Heasman PA, Benn DK, Kelly PJ, Seymour RA, Aitken D. The use of topical flurbiprofen as an adjunct to non-surgical management of periodontal disease. J Clin Periodontol 1993: 20: 457–464. 23 Heasman PA, Seymour RA. An association between long-term non-steroidal anti-inflammatory drug therapy and the severity of periodontal disease. J Clin Periodontol 1990: 17: 654–658. 24 Hefti AF, Eshenaur AE, Hassell TM, Stone C. Gingival overgrowth in cyclosporine A treated multiple sclerosis patients. J Periodontol 1994: 65: 744–749. 25 Hernandez G, Arriba L, Frias MC, De La Macorra JC, De Vicente JC, Jimenez C, De Andres A, Moreno E. Conversion from cyclosporin A to tacrolimus as a non-surgical alternative to reduce gingival enlargement: a preliminary case series. J Periodontol 2003: 74: 1816–1823. 26 Iusem R, Ballestra LH, Morris B. Clinical experiences with cortisone and ACTH in 5 cases of periodontal disease. J Periodontol 1956: 32: 655–656. 27 Jeffcoat MK, Reddy MS, Haigh S, Buchanan W, Doyle MJ, Meredith MP, Nelson SL, Goodale MB, Wehmeyer KR. A comparison of topical ketorolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis. J Periodontol 1995: 66: 329–338. 28 Kapur RN, Girgis S, Little TM, Masotti RE. Diphenylhydantoin-induced gingival hyperplasia: its relationship to dose and serum level. Dev Med Child Neurol 1973: 15: 483–487. 29 Kardachi BJ, Newcomb GM. A clinical study of gingival inflammation in renal transplant recipients taking immunosuppressive drugs. J Periodontol 1978: 49: 307–309. 30 King GN, Fullinfaw R, Higgins TJ, Walker RG, Francis DM, Wiesenfield D. Gingival hyperplasia in renal allograft recipients receiving cyclosporin-A and calcium antagonists. J Clin Periodontol 1993: 20: 286–293. 31 Krohn S. Effect of the administration of steriod hormones on the gingival tissues. J Periodontol 1958: 29: 300–306. 32 Lechler R. Mechanism of HLA and Disease. London: Academic Press, 1994: 83–91. 33 Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963: 21: 533–551. 34 Margiotta V, Pizzo I, Pizzo I, Pizzo G, Barbaro A. Cyclosporin- and nifedipine-induced gingival overgrowth in renal transplant patients: correlations with periodontal and pharmacological parameters, and HLA-antigens. J Oral Pathol Med 1996: 25: 128–134. 35 Mascarenhas P, Gapski R, Al-Shammari K, Wang HLI. Influence of sex hormones on the periodontium. J Clin Periodontol 2003: 30: 671–681. 36 Meechan JG, Seymour RA. Drug Dictionary for Dentistry 2002. Oxford: Oxford University Press, 2002. 37 Mesa FL, Osuna A, Aneiros J, Gonjzalez-Jaranay M, Bravo J, Junco P, Del Moral RG, O'Valle F. Antibiotic treatment of incipient drug-induced gingival overgrowth in adult renal transplant patients. J Periodontal Res 2003: 38: 141–146. 38 Miyazaki H, Yamashita Y, Shirahama R, Goto-Kimura K, Shimada N, Sogame A, Takehara T. Periodontal condition of pregnant women assessed by CPITN. J Clin Periodontol 1991: 18: 751–754. 39 Moshchil AI, Volozhin AI, Smetnik VP, Kangel'dieva AA, Iureneva SV. Status of tissue mineralization and the periodontium in women with impaired ovarian function. Akush Ginekol (Mosk) 1991: 10: 71–74. 40 Neumann C, Willershausen-Zèonnchen B, Klug C, Darius H. Clinical assessment of periodontal conditions in patients treated with nifedipine. Eur J Med Res 1996: 1: 273–279. 41 Nuki K, Soskolne WA, Raisz LG, Kornman KS, Alander C. Bone resorbing activity of gingiva from beagle dogs following metronidazole and indomethacin therapy. J Periodontal Res 1981: 16: 205–212. 42 Nyman S, Schroeder HE, Lindhe J. Suppression of inflammation and bone resorption by indomethacin during experimental periodontitis in dogs. J Periodontol 1979: 50: 450–461. 43 O'Neil TC, Figures KH. The effects of chlorhexidine and mechanical methods of plaque control on the recurrence of gingival hyperplasia in young patients taking phenytoin. Br Dent J 1982: 152: 130–133. 44 Oshrain HI, Mender S, Mandel ID. Periodontal status of patients with reduced immunocapacity. J Periodontol 1979: 50: 185–188. 45 O'Valle F, Mesa F, Aneiros J, Gomez-Morales M, Lucena MA, Ramirez C, Revelles F, Moreno E, Navarro N, Caballero T. Gingival overgrowth induced by nifedipine and cyclosporin A. Clinical and morphometric study with image analysis. J Clin Periodontol 1995: 22: 591–597. 46 Paganini-Hill A. The benefits of estrogen replacement therapy on oral health. The Leisure World cohort. Arch Intern Med 1995: 155: 2325–2329. 47 Paik JW, Kim CS, Cho KS, Chai JK, Kim CK, Choi SH. Inhibition of cyclosporin A-induced gingival overgrowth by azithromycin through phagocytosis: an in vivo and in vitro study. J Periodontol 2004: 75: 380–387. 48 Pernu HE, Knuuttila ML, Huttunen KR, Tiilikainen AS. Drug-induced gingival overgrowth and class II major histocompatibility antigens. Transplantation 1994: 57: 1811–1813. 49 Pernu HE, Pernu LM, Huttunen KR, Nieminen PA, Knuuttila ML. Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors. J Periodontol 1992: 63: 548–553. 50 Pernu HE, Pernu LM, Knuuttila ML. Effect of periodontal treatment on gingival overgrowth among cyclosporine A-treated renal transplant recipients. J Periodontol 1993: 64: 1098–1100. 51 Poppell TD, Keeling SD, Collins JF, Hassell TM. Effect of folic acid on recurrence of phenytoin-induced gingival overgrowth following gingivectomy. J Clin Periodontol 1991: 18: 134–139. 52 Raber-Durlacher JE, Leene W, Palmer-Bouva CC, Raber J, Abraham-Inpijn L. Experimental gingivitis during pregnancy and post-partum: immunohistochemical aspects. J Periodontol 1993: 64: 211–218. 53 Reinhardt RA, Payne JB, Maze CA, Paril KD, Gallagher SJ, Mattson JS. Influence of estrogen and osteopenia/osteoporosis on clinical periodontitis in postmenopausal women. J Periodontol 1999: 70: 823–828. 54 Royzman D, Recio L, Fiorellini J, Goodson M, Howell H. The effect of aspirin intake on bleeding on probing in patients with gingivitis. J Periodontol 2004: 75: 679–684. 55 Safkan B, Knuuttila M. Corticosteroid therapy and periodontal disease. J Clin Periodontol 1984: 11: 515–522. 56 Schuller PD, Freedman HL, Lewis DW. Periodontal status of renal transplant patients receiving immunosuppressive therapy. J Periodontol 1973: 44: 167–170. 57 Schulz A, Lange DE, Stone CE, Lison AE. Ciclosporin-induzierte Gingivahyperplasie bei Patienten mit Nierentransplantaten. Dtsch Zahnarztl Z 1990: 45: 414–416. 58 Seymour RA, Ellis JS, Thomason JM. Drug-induced gingival overgrowth and its management. J R Coll Surg Edinb 1993: 38: 328–332. 59 Seymour RA, Ellis JS, Thomason JM. Risk factors for drug-induced gingival overgrowth. J Clin Periodontol 2000: 27: 217–223. 60 Seymour RA, Heasman PA. Drugs and the periodontium. J Clin Periodontol 1988: 15: 1–16. 61 Seymour RA, Jacobs DJ. Cyclosporin and the gingival tissues. J Clin Periodontol 1992: 19: 1–11. 62 Seymour RA, Smith DG. The effect of a plaque control programme on the incidence and severity of cyclosporin-induced gingival changes. J Clin Periodontol 1991: 18: 107–110. 63 Seymour RA, Smith DG, Rogers SR. The comparative effects of azathioprine and cyclosporin on some gingival health parameters of renal transplant patients. A longitudinal study. J Clin Periodontol 1987: 14: 610–613. 64 Soga Y, Nishimura F, Ohtsuka Y, Araki H, Iwamoto Y, Naruishi H, Shiomi N, Kobayashi Y, Takashiba S, Shimizu K, Gomita Y, Oka E. CYP2C polymorphisms, phenytoin metabolism and gingival overgrowth in epileptic subjects. Life Sci 2004: 74: 827–834. 65 Somacarrera ML, Hernandez G, Acero J, Moskow BS. Localization of gingival overgrowth in transplant patients. A longitudinal study. J Periodontol 1994: 65: 666–670. 66 Somacarrera ML, Hernandez G, Acero J, Moskow BS. Factors related to the incidence and severity of cyclosporin-induced gingival overgrowth in transplant patients. A longitudinal study. J Periodontol 1994: 65: 671–675. 67 Sooriyamoorthy M, Gower DB. Hormonal influences on gingival tissue: relationship to periodontal disease. J Clin Periodontol 1989: 16: 201–208. 68 Sooriyamoorthy M, Gower DB, Eley BM. Androgen metabolism in gingival hyperplasia induced by nifedipine and cyclosporin. J Periodontal Res 1990: 25: 25–30. 69 Sooriyamoorthy M, Harvey W, Gower DB. The use of human gingival fibroblasts in culture for studying the effects of phenytoin on testosterone metabolism. Arch Oral Biol 1988: 33: 353–359. 70 Stawiniski K. Effects of corticol hormones in the treatment of periodontal disease. Dent Abstr 1960: 5: 80. 71 Strachan D, Burton I, Pearson GJ. Is oral azithromycin effective for the treatment of cyclosporine-induced gingival hyperplasia in cardiac transplant recipients? J Clin Pharm Ther 2003: 28: 329–338. 72 Tavassoli S, Yamalik N, Caglayan F, Caglayan G, Eratalay K. The clinical effects of nifedipine on periodontal status. J Periodontol 1998: 69: 108–112. 73 Thomas DW, Baboolal K, Subramanian N, Newcombe RG. Cyclosporin A-induced gingival overgrowth is unrelated to allograft function in renal transplant recipients. J Clin Periodontol 2001: 28: 706–709. 74 Thomason JM, Seymour RA, Ellis JS, Kelly PJ, Parry G, Dark J, Idle JR. Latrogenic gingival overgrowth in cardiac transplantation. J Periodontol 1995: 66: 742–746. 75 Thomason JM, Seymour RA, Ellis JS, Kelly PJ, Parry G, Dark J, Wilkinson R, Ilde JR. Determinants of gingival overgrowth severity in organ transplant patients. An examination of the role of HLA phenotype. J Clin Periodontol 1996: 23: 628–634. 76 Thomason JM, Seymour RA, Rice N. The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth. J Clin Periodontol 1993: 20: 37–40. 77 Tollefsen T, Saltvedt E, Koppang HS. The effect of immunosuppressive agents on periodontal disease in man. J Periodontal Res 1978: 13: 240–250. 78 Trackman PC, Kantarci A. Connective tissue metabolism and gingival overgrowth. Crit Rev Oral Biol Med 2004: 15: 165–175. 79 Tsai CC, Chen KS. A study on sex hormones in gingival crevicular fluid and black pigmented bacteria in subgingival plaque of pregnant women. Gaoxiong Yi Xue Ke Xue Za Zhi 1995: 11: 265–273. 80 Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971: 231: 232–235. 81 Vardar S, Baylas H, Huseyinov A. Effects of selective cyclooxygenase-2 inhibition on gingival tissue levels of prostaglandin E2 and prostaglandin F2alpha and clinical parameters of chronic periodontitis. J Periodontol 2003: 74: 57–63. 82 Varga E, Lennon MA, Mair LH. Pre-transplant gingival hyperplasia predicts severe cyclosporin-induced gingival overgrowth in renal transplant patients. J Clin Periodontol 1998: 25: 225–230. 83 Waite IM, Saxton CA, Young A, Wagg BJ, Corbett M. The periodontal status of subjects receiving non-steroidal anti-inflammatory drugs. J Periodontal Res 1981: 16: 100–108. 84 Williams RC, Jeffcoat MK, Howell TH, Rolla A, Stubbs D, Teoh KW, Reddy MS, Goldhaber P. Altering the progression of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen. J Periodontol 1989: 60: 485–490. 85 Williams RC, Jeffcoat MK, Wechter WJ, Johnson HG, Kaplan ML, Goldhaber P. Non-steroidal anti-inflammatory drug treatment of periodontitis in beagles. J Periodontal Res 1984: 19: 633–637. 86 Wilson RF, Morel A, Smith DM, Koffman CG, Rigden SP, Ashley FP. Contribution of individual drugs to gingival overgrowth in adult and juvenile renal transplant patients treated with multiple therapy. J Clin Periodontol 1998: 25: 457–464. 87 Wondimu B, Dahllof G, Berg U, Modeer T. Cyclosporin-A-induced gingival overgrowth in renal transplant children. Scand J Dent Res 1993: 101: 282–286. 88 Wondimu B, Sandberg J, Modeer T. Gingival overgrowth in renal transplant patients administered cyclosporin A in mixture or in capsule form. A longitudinal study. Clin Transplant 1996: 10: 71–76. 89 Wong W, Hodge MG, Lewis A, Sharpstone P, Kingswood JC. Resolution of cyclosporin-induced gingival hypertrophy with metronidazole. Lancet 1994: 343: 986. Citing Literature Volume40, Issue1February 2006Pages 120-129 ReferencesRelatedInformation